Back

Proteomic signatures associated with diastolic dysfunction and cardiac remodelling in a general population: insights from the Bialystok PLUS study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Reference and pathological values in echocardiography Systolic and Diastolic Function ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marlena Dubatowka

Medical University of Bialystok, Bialystok (Poland)

7 More presentations in this session

Presentation thumbnail
Myocardial hypertrabeculation: on the threshold of normality.
Professor R. Castro (Rio de Janeiro, BR)
Abstract Slides Video
Presentation thumbnail
An echocardiographic nomogram for the identification of cardiac amyloidosis in patients with left ventricular hypertrophy
Doctor S. Liang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Assessing the contribution of cycle selection to inter-observer variability in echocardiographic measurements
Doctor M. Bossa (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Stroke volume index and flow rate in the healthy population. What is normal?
Doctor I. Constantin (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Mitral annular plane systolic excursion as a single measure for the non-invasive assessment of left ventricular filling pressures.
Doctor C. Carlos Adrian (Santa Fe, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Reference and pathological values in echocardiography

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Blood protein profile of left ventricular diastolic function
thumbnail
Congress Presentation
Proteomic profiling of left atrial strain provides new plasma proteins that may be associated with the development or early complications of cardiovascular disease (CVD)
thumbnail
Congress Presentation
Proteomic analysis of potential biomarkers of recent onset dilated cardiomyopathy for prediction of the therapy outcome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources